Products

Quality Control
We are actively taking measures to improve product quality levels.

Applications

Why Hamamatsu?

Support

Our Company

( )

Select your region and country.

Invests in Armonica Technologies, inc.

We participated in the Series B funding of Armonica technologies, inc. which is developing a next-generation sequencer using optical technology. Armonica's approach will lead to faster, more thorough and more accurate genomic analysis than is currently available, without the need for extensive workflow and reagents. By investing in Armonica's technology we hope to speed the development of new and more effective treatments to some of the world's most devastating diseases."